ARQT:NASDAQ, Arcutis Biotherapeutics, Inc.

ARQT stock overview

Arcutis Biotherapeutics, Inc. (ARQT:NASDAQ) closed at $31.95 on October 27, 2026, up 0.42% on the day. The stock trades 4.1% below its 52-week high of $33.30 and 65.6% above its 52-week low of $19.30. Over the past year, it gained 62.0%. Arcutis Biotherapeutics, Inc. is part of the Health Care sector.

Key figures

Price: $31.95
Day change: +0.42%
Volume: 220,685
Average volume: 2,467,392
Market cap: 4B+
52-week range: $19.30 – $33.30
50-day average: $26.20
200-day average: $25.15

Price action over the past year

In 252 trading sessions since October 24, 2025, ARQT closed higher on 126 days (50%). Its best day was October 28, 2025 (+27.04%) and its worst was May 7, 2026 (-14.52%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Oct 21, 2026: News catalyst: Earnings (News Catalysts scanner)

ARQT news

Oct 21, 2026: Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
Oct 20, 2026: Arcutis Biotherapeutics (ARQT) Gets New Rating Uprgades from 2 Analysts; Shares Climb
Oct 19, 2026: Clinical Data Update Could Shape The Case For Arcutis Biotherapeutics Stock
Oct 19, 2026: Arcutis Soars 12% as Guggenheim Lifts Target to $44 on “Growing Conviction” in 2027
Oct 12, 2026: 2 Stocks That Could Soar in Q4
Oct 10, 2026: Arcutis Biotherapeutics (ARQT) Showcased Fresh ZORYVE Data, Is It Still 28% Below Fair Value?
Oct 9, 2026: Arcutis Presents ZORYVE (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
Oct 9, 2026: Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical

About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. The company targets immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Similar stocks

Find more stocks like ARQT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.